Odyssey Therapeutics, Inc.(ODTX)
$20.10-0.89 (-4.24%)
ODTX
Odyssey Therapeutics, Inc. hedge funds
$20.10
At close:-0.89 (-4.24%)
Odyssey Therapeutics, Inc. (ODTX) Hedge Fund Trading Activity
14 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 0 Shares Last Quarter
Hedge Fund Holdings in ODTX
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 James E. Flynn | Deerfield Management Company, LP | New | 100.00% | $19,573,261 | 0.20% | ||
 Michael Rockefeller | Woodline Partners LP | New | 100.00% | $6,468,908 | 0.02% | ||
| BlackRock, Inc. | New | 100.00% | $4,503,104 | <0.01% | |||
| Otello Stampacchia | Omega Fund Management, LLC | New | 100.00% | $54,128 | 0.03% |
FAQ
Which hedge funds hold Odyssey Therapeutics, Inc.?
The hedge funds that hold the most shares in Odyssey Therapeutics, Inc. are BlackRock, Inc., James E. Flynn and Michael Rockefeller.
Are hedge funds buying or selling ODTX?
In the last quarter hedge funds have Increased their holdings in Odyssey Therapeutics, Inc. by 0 shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Odyssey Therapeutics, Inc. stock?
Warren Buffet currently does not own shares in Odyssey Therapeutics, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
